SRPT 118 (+0.8%)
US8036071004BiotechnologyBiotechnology

Sarepta Therapeutics (SRPT) Stock Highlights

118 | +0.8%
2025-01-21 01:14:39
Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sareptas strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sareptas product candidates are at an early stage of development.

Statistics

Range Today
115.61 118.45
Volume Today 649.1K
Range 1 Year
102.16 173.25
Volume 1 Year 293.6M
Range 3 Year
55.25 173.25
Volume 3 Year 877.68M
Range 10 Year
8 181.83
Volume 10 Year 4.05B

Highlights

Market Capitalization 11.27B (large)
Floating Shares 91.15M
Current Price 118
Price To Earnings 75.97
Price To Revenue 6.95
Price To Book 9.23
Earnings Per Share 1.55
Payout Ratio 0%

Performance

Latest +0.8%
1 Month -5.68%
3 Months -6.05%
6 Months -20.01%
1 Year +2.77%
3 Years +68.76%
5 Years -9.4%
10 Years +872.79%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.